Cargando…

TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III

BACKGROUND: Transmembrane protein 106B (TMEM106B) has been identified as a risk factor for frontotemporal lobar degeneration, which is the second most common form of progressive dementia in people under 65 years of age. Mutations in charged multivesicular body protein 2B (CHMP2B), which is involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Mi-Hee, Han, Jeong-Ho, Lee, Yu-Kyung, Jang, Deok-Jin, Kaang, Bong-Kiun, Lee, Jin-A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676093/
https://www.ncbi.nlm.nih.gov/pubmed/26651479
http://dx.doi.org/10.1186/s13041-015-0177-z
_version_ 1782405109149335552
author Jun, Mi-Hee
Han, Jeong-Ho
Lee, Yu-Kyung
Jang, Deok-Jin
Kaang, Bong-Kiun
Lee, Jin-A
author_facet Jun, Mi-Hee
Han, Jeong-Ho
Lee, Yu-Kyung
Jang, Deok-Jin
Kaang, Bong-Kiun
Lee, Jin-A
author_sort Jun, Mi-Hee
collection PubMed
description BACKGROUND: Transmembrane protein 106B (TMEM106B) has been identified as a risk factor for frontotemporal lobar degeneration, which is the second most common form of progressive dementia in people under 65 years of age. Mutations in charged multivesicular body protein 2B (CHMP2B), which is involved in endosomal protein trafficking, have been found in chromosome 3-linked frontotemporal dementia. Despite the number of studies on both CHMP2B and TMEM106B in the endolysosomal pathway, little is known about the relationship between CHMP2B and TMEM106B in the endosomal/autophagy pathway. RESULTS: This study found that endogenous TMEM106B was partially sequestered in CHMP2B-positive structures, suggesting its possible involvement in endosomal sorting complexes required for transport (ESCRT)-associated pathways. The role of single nucleotide polymorphisms of TMEM106B (T185, S185, or S134N) in the ESCRT-associated pathways were characterized. The T185 and S185 variants were more localized to Rab5-/Rab7-positive endosomes compared with S134N, while all of the variants were more localized to Rab7-positive endosomes compared to Rab5-positive endosomes. T185 was more associated with CHMP2B compared to S185. Autophagic flux was slightly reduced in the T185-expressing cells compared to the control or S185-expressing cells. Moreover, T185 slightly enhanced the accumulation of EGFR, impairments in autophagic flux, and neurotoxicity that were caused by CHMP2B(Intron5) compared to S185-expressing cells. CONCLUSIONS: These findings suggest that the T185 variant functions as a risk factor in neurodegeneration with endolysosomal defects. This study provides a better understanding of pathogenic functions of TMEM106B, which is a risk factor for the progression of neurodegenerative diseases that are associated with endosomal defects in the aged brain. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13041-015-0177-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4676093
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46760932015-12-12 TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III Jun, Mi-Hee Han, Jeong-Ho Lee, Yu-Kyung Jang, Deok-Jin Kaang, Bong-Kiun Lee, Jin-A Mol Brain Short Report BACKGROUND: Transmembrane protein 106B (TMEM106B) has been identified as a risk factor for frontotemporal lobar degeneration, which is the second most common form of progressive dementia in people under 65 years of age. Mutations in charged multivesicular body protein 2B (CHMP2B), which is involved in endosomal protein trafficking, have been found in chromosome 3-linked frontotemporal dementia. Despite the number of studies on both CHMP2B and TMEM106B in the endolysosomal pathway, little is known about the relationship between CHMP2B and TMEM106B in the endosomal/autophagy pathway. RESULTS: This study found that endogenous TMEM106B was partially sequestered in CHMP2B-positive structures, suggesting its possible involvement in endosomal sorting complexes required for transport (ESCRT)-associated pathways. The role of single nucleotide polymorphisms of TMEM106B (T185, S185, or S134N) in the ESCRT-associated pathways were characterized. The T185 and S185 variants were more localized to Rab5-/Rab7-positive endosomes compared with S134N, while all of the variants were more localized to Rab7-positive endosomes compared to Rab5-positive endosomes. T185 was more associated with CHMP2B compared to S185. Autophagic flux was slightly reduced in the T185-expressing cells compared to the control or S185-expressing cells. Moreover, T185 slightly enhanced the accumulation of EGFR, impairments in autophagic flux, and neurotoxicity that were caused by CHMP2B(Intron5) compared to S185-expressing cells. CONCLUSIONS: These findings suggest that the T185 variant functions as a risk factor in neurodegeneration with endolysosomal defects. This study provides a better understanding of pathogenic functions of TMEM106B, which is a risk factor for the progression of neurodegenerative diseases that are associated with endosomal defects in the aged brain. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13041-015-0177-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-10 /pmc/articles/PMC4676093/ /pubmed/26651479 http://dx.doi.org/10.1186/s13041-015-0177-z Text en © Jun et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Jun, Mi-Hee
Han, Jeong-Ho
Lee, Yu-Kyung
Jang, Deok-Jin
Kaang, Bong-Kiun
Lee, Jin-A
TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
title TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
title_full TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
title_fullStr TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
title_full_unstemmed TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
title_short TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
title_sort tmem106b, a frontotemporal lobar dementia (ftld) modifier, associates with ftd-3-linked chmp2b, a complex of escrt-iii
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676093/
https://www.ncbi.nlm.nih.gov/pubmed/26651479
http://dx.doi.org/10.1186/s13041-015-0177-z
work_keys_str_mv AT junmihee tmem106bafrontotemporallobardementiaftldmodifierassociateswithftd3linkedchmp2bacomplexofescrtiii
AT hanjeongho tmem106bafrontotemporallobardementiaftldmodifierassociateswithftd3linkedchmp2bacomplexofescrtiii
AT leeyukyung tmem106bafrontotemporallobardementiaftldmodifierassociateswithftd3linkedchmp2bacomplexofescrtiii
AT jangdeokjin tmem106bafrontotemporallobardementiaftldmodifierassociateswithftd3linkedchmp2bacomplexofescrtiii
AT kaangbongkiun tmem106bafrontotemporallobardementiaftldmodifierassociateswithftd3linkedchmp2bacomplexofescrtiii
AT leejina tmem106bafrontotemporallobardementiaftldmodifierassociateswithftd3linkedchmp2bacomplexofescrtiii